Disease model: LAMP-2 enlightens Danon disease

Trends in Molecular Medicine

Volumn 7, Issue 1, 2001, Pages 37-39

  Saftig, Paul ^a   Von Figura, Kurt ^a   Tanaka, Yshitaka ^b   Lüllmann Rauch, Renate ^c  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b KYUSHU UNIVERSITY   (Japan)

^c UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAN 1,4 ALPHA GLUCOSIDASE; LYSOSOME ASSOCIATED MEMEBRANE PROTEIN 2; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOPHAGY; CARDIOMYOPATHY; GENE MUTATION; GENE SEQUENCE; GLYCOGEN STORAGE DISEASE; HEART FAILURE; HUMAN; LYSOSOME STORAGE DISEASE; MENTAL DEFICIENCY; MOUSE; MYOPATHY; NONHUMAN; REVIEW; X CHROMOSOME LINKED DISORDER;

ANIMALIA;

EID: 0034475043     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(00)01868-2     Document Type: Review

References (9)

1. Lysosomal glycogen storage disease with normal acid maltase
2. Nosology of lysosomal glycogen storage diseases without in vitro acid maltase deficiency. Delineation of a neonatal form
3. Lysosomal glycogen storage with normal acid maltase: A familial study with successful heart transplant
4. Lysosomal glycogen storage disease without acid maltase deficiency
5. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)
6. Biogenesis of the lysosomal membrane
7. Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2 deficient mice
8. Hepatic involvement in a case of lysosomal glycogen storage disease with normal acid maltase
9. Studies on the mechanisms of autophagy: Formation of the autophagic vacuole